APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cells

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Selected research

Market Analysis & Forecast

Global Mesenchymal Stem Cells Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cells Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cells Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cells Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cells Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

Read the full market overview

Report Includes

This report presents an overview of global market for Mesenchymal Stem Cells, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mesenchymal Stem Cells, also provides the revenue of main regions and countries. Of the upcoming market potential for Mesenchymal Stem Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mesenchymal Stem Cells revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mesenchymal Stem Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mesenchymal Stem Cells revenue, projected growth trends, production technology, application and end-user industry.

Mesenchymal Stem Cells Segment by Company

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Mesenchymal Stem Cells Segment by Type

Human MSC

Mouse MSC

Rat MSC

Others

Mesenchymal Stem Cells Segment by Application

Research Institute

Hospital

Others

Mesenchymal Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Mesenchymal Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesenchymal Stem Cells revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human MSC Major Player Table 3. Mouse MSC Major Player Table 4. Rat MSC Major Player Table 5. Others Major Player Table 6. Global Mesenchymal Stem Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Research Institute Major Player Table 8. Hospital Major Player Table 9. Others Major Player Table 10. Mesenchymal Stem Cells Industry Trends Table 11. Mesenchymal Stem Cells Industry Drivers Table 12. Mesenchymal Stem Cells Industry Opportunities and Challenges Table 13. Mesenchymal Stem Cells Industry Restraints Table 14. Global Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Mesenchymal Stem Cells Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Mesenchymal Stem Cells Market Share by Region (2021-2026) Table 17. Global Mesenchymal Stem Cells Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Mesenchymal Stem Cells Market Share by Region (2027-2032) Table 19. Global Mesenchymal Stem Cells Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Mesenchymal Stem Cells Revenue Market Share by Players (2021-2026) Table 21. Global Mesenchymal Stem Cells Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Mesenchymal Stem Cells Key Players Headquarters & Area Served Table 23. Global Mesenchymal Stem Cells Players, Product Type & Application Table 24. Global Mesenchymal Stem Cells Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Mesenchymal Stem Cells by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Mesenchymal Stem Cells Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021-2026) Table 31. Global Mesenchymal Stem Cells Revenue Market Share by Type (2027-2032) Table 32. Global Mesenchymal Stem Cells Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021-2026) Table 36. Global Mesenchymal Stem Cells Revenue Market Share by Application (2027-2032) Table 37. Lonza Company Information Table 38. Lonza Business Overview Table 39. Lonza Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Lonza Mesenchymal Stem Cells Product Portfolio Table 41. Lonza Recent Development Table 42. Thermo Fisher Company Information Table 43. Thermo Fisher Business Overview Table 44. Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Thermo Fisher Mesenchymal Stem Cells Product Portfolio Table 46. Thermo Fisher Recent Development Table 47. Bio-Techne Company Information Table 48. Bio-Techne Business Overview Table 49. Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bio-Techne Mesenchymal Stem Cells Product Portfolio Table 51. Bio-Techne Recent Development Table 52. ATCC Company Information Table 53. ATCC Business Overview Table 54. ATCC Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. ATCC Mesenchymal Stem Cells Product Portfolio Table 56. ATCC Recent Development Table 57. MilliporeSigma Company Information Table 58. MilliporeSigma Business Overview Table 59. MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. MilliporeSigma Mesenchymal Stem Cells Product Portfolio Table 61. MilliporeSigma Recent Development Table 62. PromoCell GmbH Company Information Table 63. PromoCell GmbH Business Overview Table 64. PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio Table 66. PromoCell GmbH Recent Development Table 67. Genlantis Company Information Table 68. Genlantis Business Overview Table 69. Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Genlantis Mesenchymal Stem Cells Product Portfolio Table 71. Genlantis Recent Development Table 72. Celprogen Company Information Table 73. Celprogen Business Overview Table 74. Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Celprogen Mesenchymal Stem Cells Product Portfolio Table 76. Celprogen Recent Development Table 77. Cell Applications Company Information Table 78. Cell Applications Business Overview Table 79. Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Cell Applications Mesenchymal Stem Cells Product Portfolio Table 81. Cell Applications Recent Development Table 82. Cyagen Biosciences Company Information Table 83. Cyagen Biosciences Business Overview Table 84. Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio Table 86. Cyagen Biosciences Recent Development Table 87. Axol Bioscience Company Information Table 88. Axol Bioscience Business Overview Table 89. Axol Bioscience Mesenchymal Stem Cells Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Axol Bioscience Mesenchymal Stem Cells Product Portfolio Table 91. Axol Bioscience Recent Development Table 92. North America Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Mesenchymal Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Mesenchymal Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Mesenchymal Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Mesenchymal Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 106. China Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 107. China Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 108. China Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 109. China Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Mesenchymal Stem Cells Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Mesenchymal Stem Cells Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Mesenchymal Stem Cells Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Mesenchymal Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Mesenchymal Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Mesenchymal Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Mesenchymal Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Mesenchymal Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Mesenchymal Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Mesenchymal Stem Cells Image Figure 2. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesenchymal Stem Cells Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human MSC Image Figure 5. Mouse MSC Image Figure 6. Rat MSC Image Figure 7. Others Image Figure 8. Global Mesenchymal Stem Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Mesenchymal Stem Cells Market Size Share 2021 VS 2025 VS 2032 Figure 10. Research Institute Image Figure 11. Hospital Image Figure 12. Others Image Figure 13. Global Mesenchymal Stem Cells Market Size (US$ Million) & (2021-2032) Figure 14. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Mesenchymal Stem Cells Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Mesenchymal Stem Cells Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Mesenchymal Stem Cells Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Mesenchymal Stem Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021-2032) Figure 21. Global Mesenchymal Stem Cells Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021-2032) Figure 24. North America Mesenchymal Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Mesenchymal Stem Cells Revenue Share by Type (2021-2032) Figure 26. North America Mesenchymal Stem Cells Revenue Share by Application (2021-2032) Figure 27. North America Mesenchymal Stem Cells Revenue Share by Country (2021-2032) Figure 28. United States Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Mesenchymal Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Mesenchymal Stem Cells Revenue Share by Type (2021-2032) Figure 33. Europe Mesenchymal Stem Cells Revenue Share by Application (2021-2032) Figure 34. Europe Mesenchymal Stem Cells Revenue Share by Country (2021-2032) Figure 35. Germany Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Mesenchymal Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Mesenchymal Stem Cells Revenue Share by Type (2021-2032) Figure 45. China Mesenchymal Stem Cells Revenue Share by Application (2021-2032) Figure 46. Asia Mesenchymal Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Mesenchymal Stem Cells Revenue Share by Type (2021-2032) Figure 48. Asia Mesenchymal Stem Cells Revenue Share by Application (2021-2032) Figure 49. Asia Mesenchymal Stem Cells Revenue Share by Region (2021-2032) Figure 50. Japan Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Mesenchymal Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Mesenchymal Stem Cells Revenue Share by Type (2021-2032) Figure 58. SAMEA Mesenchymal Stem Cells Revenue Share by Application (2021-2032) Figure 59. SAMEA Mesenchymal Stem Cells Revenue Share by Country (2021-2032) Figure 60. Brazil Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Mesenchymal Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Lonza
  • Thermo Fisher
  • Bio-Techne
  • ATCC
  • MilliporeSigma
  • PromoCell GmbH
  • Genlantis
  • Celprogen
  • Cell Applications
  • Cyagen Biosciences
  • Axol Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mesenchymal Stem Cells Market by Type
  3. 1.2.1 Global Mesenchymal Stem Cells Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human MSC
  5. 1.2.3 Mouse MSC
  6. 1.2.4 Rat MSC
  7. 1.2.5 Others
  8. 1.3 Mesenchymal Stem Cells Market by Application
  9. 1.3.1 Global Mesenchymal Stem Cells Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institute
  11. 1.3.3 Hospital
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Mesenchymal Stem Cells Market Dynamics
  1. 2.1 Mesenchymal Stem Cells Industry Trends
  2. 2.2 Mesenchymal Stem Cells Industry Drivers
  3. 2.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
  4. 2.4 Mesenchymal Stem Cells Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Mesenchymal Stem Cells Market Perspective (2021-2032)
  2. 3.2 Global Mesenchymal Stem Cells Growth Trends by Region
  3. 3.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mesenchymal Stem Cells Market Size by Region (2021-2026)
  5. 3.2.3 Global Mesenchymal Stem Cells Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Mesenchymal Stem Cells Revenue by Players
  2. 4.1.1 Global Mesenchymal Stem Cells Revenue by Players (2021-2026)
  3. 4.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Mesenchymal Stem Cells Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mesenchymal Stem Cells Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Mesenchymal Stem Cells Key Players Headquarters & Area Served
  7. 4.4 Global Mesenchymal Stem Cells Players, Product Type & Application
  8. 4.5 Global Mesenchymal Stem Cells Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Mesenchymal Stem Cells Market CR5 and HHI
  11. 4.6.3 2025 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier 3
5 Mesenchymal Stem Cells Market Size by Type
  1. 5.1 Global Mesenchymal Stem Cells Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 5.3 Global Mesenchymal Stem Cells Revenue Market Share by Type (2021-2032)
6 Mesenchymal Stem Cells Market Size by Application
  1. 6.1 Global Mesenchymal Stem Cells Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Mesenchymal Stem Cells Revenue by Application (2021-2032)
  3. 6.3 Global Mesenchymal Stem Cells Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza
  2. 7.1.1 Lonza Company Information
  3. 7.1.2 Lonza Business Overview
  4. 7.1.3 Lonza Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
  6. 7.1.5 Lonza Recent Developments
  7. 7.2 Thermo Fisher
  8. 7.2.1 Thermo Fisher Company Information
  9. 7.2.2 Thermo Fisher Business Overview
  10. 7.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
  12. 7.2.5 Thermo Fisher Recent Developments
  13. 7.3 Bio-Techne
  14. 7.3.1 Bio-Techne Company Information
  15. 7.3.2 Bio-Techne Business Overview
  16. 7.3.3 Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
  18. 7.3.5 Bio-Techne Recent Developments
  19. 7.4 ATCC
  20. 7.4.1 ATCC Company Information
  21. 7.4.2 ATCC Business Overview
  22. 7.4.3 ATCC Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
  24. 7.4.5 ATCC Recent Developments
  25. 7.5 MilliporeSigma
  26. 7.5.1 MilliporeSigma Company Information
  27. 7.5.2 MilliporeSigma Business Overview
  28. 7.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
  30. 7.5.5 MilliporeSigma Recent Developments
  31. 7.6 PromoCell GmbH
  32. 7.6.1 PromoCell GmbH Company Information
  33. 7.6.2 PromoCell GmbH Business Overview
  34. 7.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
  36. 7.6.5 PromoCell GmbH Recent Developments
  37. 7.7 Genlantis
  38. 7.7.1 Genlantis Company Information
  39. 7.7.2 Genlantis Business Overview
  40. 7.7.3 Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
  42. 7.7.5 Genlantis Recent Developments
  43. 7.8 Celprogen
  44. 7.8.1 Celprogen Company Information
  45. 7.8.2 Celprogen Business Overview
  46. 7.8.3 Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
  48. 7.8.5 Celprogen Recent Developments
  49. 7.9 Cell Applications
  50. 7.9.1 Cell Applications Company Information
  51. 7.9.2 Cell Applications Business Overview
  52. 7.9.3 Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
  54. 7.9.5 Cell Applications Recent Developments
  55. 7.10 Cyagen Biosciences
  56. 7.10.1 Cyagen Biosciences Company Information
  57. 7.10.2 Cyagen Biosciences Business Overview
  58. 7.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
  60. 7.10.5 Cyagen Biosciences Recent Developments
  61. 7.11 Axol Bioscience
  62. 7.11.1 Axol Bioscience Company Information
  63. 7.11.2 Axol Bioscience Business Overview
  64. 7.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
  66. 7.11.5 Axol Bioscience Recent Developments
8 North America
  1. 8.1 North America Mesenchymal Stem Cells Revenue (2021-2032)
  2. 8.2 North America Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 8.2.1 North America Mesenchymal Stem Cells Revenue by Type (2021-2026)
  4. 8.2.2 North America Mesenchymal Stem Cells Revenue by Type (2027-2032)
  5. 8.3 North America Mesenchymal Stem Cells Revenue Share by Type (2021-2032)
  6. 8.4 North America Mesenchymal Stem Cells Revenue by Application (2021-2032)
  7. 8.4.1 North America Mesenchymal Stem Cells Revenue by Application (2021-2026)
  8. 8.4.2 North America Mesenchymal Stem Cells Revenue by Application (2027-2032)
  9. 8.5 North America Mesenchymal Stem Cells Revenue Share by Application (2021-2032)
  10. 8.6 North America Mesenchymal Stem Cells Revenue by Country
  11. 8.6.1 North America Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Mesenchymal Stem Cells Revenue by Country (2021-2026)
  13. 8.6.3 North America Mesenchymal Stem Cells Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Mesenchymal Stem Cells Revenue (2021-2032)
  2. 9.2 Europe Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 9.2.1 Europe Mesenchymal Stem Cells Revenue by Type (2021-2026)
  4. 9.2.2 Europe Mesenchymal Stem Cells Revenue by Type (2027-2032)
  5. 9.3 Europe Mesenchymal Stem Cells Revenue Share by Type (2021-2032)
  6. 9.4 Europe Mesenchymal Stem Cells Revenue by Application (2021-2032)
  7. 9.4.1 Europe Mesenchymal Stem Cells Revenue by Application (2021-2026)
  8. 9.4.2 Europe Mesenchymal Stem Cells Revenue by Application (2027-2032)
  9. 9.5 Europe Mesenchymal Stem Cells Revenue Share by Application (2021-2032)
  10. 9.6 Europe Mesenchymal Stem Cells Revenue by Country
  11. 9.6.1 Europe Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Mesenchymal Stem Cells Revenue by Country (2021-2026)
  13. 9.6.3 Europe Mesenchymal Stem Cells Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Mesenchymal Stem Cells Revenue (2021-2032)
  2. 10.2 China Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 10.2.1 China Mesenchymal Stem Cells Revenue by Type (2021-2026)
  4. 10.2.2 China Mesenchymal Stem Cells Revenue by Type (2027-2032)
  5. 10.3 China Mesenchymal Stem Cells Revenue Share by Type (2021-2032)
  6. 10.4 China Mesenchymal Stem Cells Revenue by Application (2021-2032)
  7. 10.4.1 China Mesenchymal Stem Cells Revenue by Application (2021-2026)
  8. 10.4.2 China Mesenchymal Stem Cells Revenue by Application (2027-2032)
  9. 10.5 China Mesenchymal Stem Cells Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mesenchymal Stem Cells Revenue (2021-2032)
  2. 11.2 Asia Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 11.2.1 Asia Mesenchymal Stem Cells Revenue by Type (2021-2026)
  4. 11.2.2 Asia Mesenchymal Stem Cells Revenue by Type (2027-2032)
  5. 11.3 Asia Mesenchymal Stem Cells Revenue Share by Type (2021-2032)
  6. 11.4 Asia Mesenchymal Stem Cells Revenue by Application (2021-2032)
  7. 11.4.1 Asia Mesenchymal Stem Cells Revenue by Application (2021-2026)
  8. 11.4.2 Asia Mesenchymal Stem Cells Revenue by Application (2027-2032)
  9. 11.5 Asia Mesenchymal Stem Cells Revenue Share by Application (2021-2032)
  10. 11.6 Asia Mesenchymal Stem Cells Revenue by Country
  11. 11.6.1 Asia Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Mesenchymal Stem Cells Revenue by Country (2021-2026)
  13. 11.6.3 Asia Mesenchymal Stem Cells Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mesenchymal Stem Cells Revenue (2021-2032)
  2. 12.2 SAMEA Mesenchymal Stem Cells Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Mesenchymal Stem Cells Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Mesenchymal Stem Cells Revenue by Type (2027-2032)
  5. 12.3 SAMEA Mesenchymal Stem Cells Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Mesenchymal Stem Cells Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Mesenchymal Stem Cells Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Mesenchymal Stem Cells Revenue by Application (2027-2032)
  9. 12.5 SAMEA Mesenchymal Stem Cells Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Mesenchymal Stem Cells Revenue by Country
  11. 12.6.1 SAMEA Mesenchymal Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Mesenchymal Stem Cells Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Mesenchymal Stem Cells Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst